Thermo Fisher Scientific Delivers On-Site Services Management Project to Organon
ALTRINCHAM, UK (June 12, 2007) - Thermo Fisher Scientific Inc., the world leader in serving science, has established a new partnership with leading pharmaceutical research company Organon, to provide its Asset Management Services to Organon's research facility at Newhouse, Scotland. As part of the contract, Thermo Fisher will supply simplified, cost-effective, one stop service delivery solutions to the Organon site, a pharmaceutical drug discovery facility.
The new project aims to simplify on-site maintenance and service contracts while saving time and money for Organon. With approximately 300 scientific staff members at the Scotland site, Organon's service requirements are growing at a fast pace. Thermo Fisher's European Asset Management Services team is working with Organon to roll out a site implementation plan, streamlining the various methods used to deal with on-site maintenance as well as consolidating external service contracts.
Thermo Fisher has appointed a designated team to work with Organon, including a project manager who will oversee each stage of the project. Beginning with a full inventory of Organon's instruments and inputting all information into an internal database, the team has been working closely with Organon staff to document the company's site inventory and to determine the necessary range of services, thereby creating the optimal solution. Each project is treated individually, and the maintenance solutions could involve Thermo Fisher taking over the management of all aspects of maintenance, keeping the existing maintenance contracts or a mix of the two approaches. The objective is to reduce the administrative workload from Organon's scientists, allowing them to focus on science instead of managing service suppliers.
Carolina Schwegler, operations director for Europe, Asset Management Services for Thermo Fisher Scientific, comments, "Organon is already seeing great results since implementing our program. The tailored program and processes that our European team has put in place along with the ongoing dialogue with the Organon team has resulted in better information to help them measure their true service needs and the type of ongoing support required."
Ron MacKenzie, procurement director for Organon, adds, "Organon's levels of service remain high, as before, but with Thermo Fisher managing the service delivery contracts, new processes have been put in place to manage interaction with both instrument manufacturers and end-users, saving Organon both time and money."
The European Asset Management Services team is headquartered in the UK, providing close support to its European customers and comprises service experts in the life and laboratory markets as well as government agencies.
For more information about Thermo Scientific Asset Management Services please call on 1 800 558 6377 and in Europe + 44 (0)161 942 2950, or visit www.thermo.com
Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.
About Organon
Organon creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage its position as a leading biopharmaceutical company in each of its core therapeutic fields: fertility, gynecology and selected areas of anesthesia. It has extensive expertise in neuroscience and a rich and focused R&D program. Research areas also include immunology and specific areas of oncology. Organon products are distributed in over 100 countries worldwide, of which more than 50 have an Organon subsidiary. Organon is the human healthcare business unit of Akzo Nobel.
